1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514383, 514384, 548252, 548253, 548254, 5482622, 5482642, 5482668, 5482682, 5482678, 5482694, A61K 3141, C07D24912, C07D24908

Patent

active

051400367

ABSTRACT:
A class of 1,3,5-trisubstituted-1,2,4-triazole compounds is described for use in treatment of circulatory disorders. Compounds of particular interest are angiotensin II antagonists of the formula ##STR1## wherein m is one; wherein R.sup.1 is selected from ethyl, n-propyl, isopropyl, butyl, isobutyl, tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, benzyl, cyclohexyl, cyclohexymethyl, 2-butenyl, 3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein R.sup.2 is selected from ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, 4-methylbutyl, tert-butyl, n-pentyl, neo-pentyl, 1-oxoethyl, 1-oxopropyl, 1-oxobutyl, 1-oxopentyl, 1,1-dimethoxypropyl, 1,1-dimethoxypentyl, halo, difluoromethyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 1,1-difluoro-3-cyclohexypropyl, 1,1-dimethoxybutyl, 1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, cyclohexanoyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and butylthio; wherein each of R.sup.3 through R.sup.11 is hydrido with the proviso that at least one of R.sup.5 and R.sup.9 must be selected from COOH, SH, PO.sub.3 H.sub.2, SO.sub.3 H, CONHNH.sub.2, CONHNHSO.sub.2 CF.sub.3, OH, ##STR2## wherein each of R.sup.42 and R.sup.43 is independently selected from chloro, cyano, nitro, trifluoromethyl, methoxycarbonyl and trifluoromethylsulfonyl. These compounds are particularly useful in treatment or control of hypertension and congestive heart failure.

REFERENCES:
patent: 3857845 (1974-12-01), Palazzo
patent: 4294972 (1981-10-01), Cassidy et al.
patent: 4816463 (1989-03-01), Blankley et al.
patent: 4880804 (1989-11-01), Carini et al.
Burger, A. Medicinal Chemistry, 2nd Ed. New York, pp. 565-571, 578-581, 600-601 (1960).
Denkewalter et al., Progress in Drug Research, vol. 10, pp. 510-512 (1966).
P. C. Wong et al., J. Pharmacol. Exp. Ther., 247(1), 1-7 (1988).
A. T. Chiu et al., European J. Pharmacol., 157, 13-21 (1988).
A. T. Chiu et al., J. Pharmacol. Exp. Ther., 250(3), 867-874 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1249273

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.